Purpose The paper aims to assess the impact of corporate strategy on shareholder value in decline and turnaround situations. Design/methodology/approach A sample of 45 turnaround firms was selected and matched against a control sample which did not face continuous decline over the time period studied. The impact of corporate strategy on shareholder value was tested using cumulative beta excess return measures to capture the long‐term basis of corporate strategy. Findings The paper finds that the beta excess return measures captured the hypothesized relationships between strategy and shareholder value for the sample firms studied. Practical implications Beta excess return measures are superior to case studies or event studies for identifying the long‐term effects of corporate strategy. Originality/value Relatively few studies have compared the strategies of turnaround firms with a matched sample of non‐declining firms. The use of cumulative beta excess returns to assess long‐term valuation of corporate strategy is original.
No takes yet. Share an insight, caveat, or question.
Olivier Furrer (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: